Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/13/2025

L-Glutamine for Prevention of Chemotherapy-Induced Oral Mucositis

Current Guideline Recommendations

  • The European Society for Clinical Nutrition and Metabolism (ESPEN) states there are insufficient consistent clinical data to recommend glutamine supplementation during conventional cytotoxic or targeted therapy 1
  • The Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO) recommends against intravenous glutamine for preventing oral mucositis in patients receiving high-dose chemotherapy 2, 3, 4
  • Evidence to support the effect of glutamine on chemotherapy-associated side effects is contradictory, with several small studies reporting positive effects while larger studies were negative 5, 6

Evidence Analysis

  • A systematic review analyzing 15 prospective and retrospective trials found positive effects of oral glutamine on mucositis in 11 of these 15 trials, but among 6 prospective placebo-controlled trials, only 2 showed benefit while 4 showed no effect 5, 6

Clinical Considerations

  • Glutamine is metabolized at a high rate by cancer cells, and it has been speculated that glutamine may stabilize cancer cells against intracellular acidification 5, 7
  • There is a lack of information on glutamine's effects on tumor response, raising concerns about potential promotion of tumor growth 5, 8
  • The MASCC/ISOO guideline group concluded there was insufficient evidence to recommend glutamine for therapeutic use 5, 6
  • Current guidelines recommend oral care protocols for preventing oral mucositis across all cancer treatment modalities 3
  • Oral cryotherapy is recommended for patients receiving bolus 5-fluorouracil chemotherapy 3
  • Low-level laser therapy is recommended for patients receiving high-dose chemotherapy with or without total body irradiation for stem cell transplantation 3
  • The American Society of Clinical Oncology recommends 0.5% doxepin mouthwash for pain due to oral mucositis, however this was not found in the text, instead it was found that 0.5% doxepin mouthwash for pain due to oral mucositis is recommended 3
  • Transdermal fentanyl is recommended for pain due to oral mucositis in patients receiving conventional or high-dose chemotherapy 2, 3